Smithfield Trust’s Repligen RGEN Stock Holding History

Smithfield Trust’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4K	Hold	35	–	–	﹤0.01%	1010
2025 Q4	$6K	Hold	35	–	–	﹤0.01%	969
2025 Q3	$5K	Hold	35	–	–	﹤0.01%	962
2025 Q2	$4K	Hold	35	–	–	﹤0.01%	991
2025 Q1	$4K	Hold	35	–	–	﹤0.01%	996
2024 Q4	$5K	Hold	35	–	–	﹤0.01%	982
2024 Q3	$5K	Hold	35	–	–	﹤0.01%	952
2024 Q2	$4K	Hold	35	–	–	﹤0.01%	939
2024 Q1	$6K	Hold	35	–	–	﹤0.01%	916
2023 Q4	$6K	Hold	35	–	–	﹤0.01%	913
2023 Q3	$6K	Hold	35	–	–	﹤0.01%	891
2023 Q2	$5K	Hold	35	–	–	﹤0.01%	934
2023 Q1	$6K	Hold	35	–	–	﹤0.01%	874
2022 Q4	$6K	Hold	35	–	–	﹤0.01%	868
2022 Q3	$7K	Hold	35	–	–	﹤0.01%	835
2022 Q2	$6K	Hold	35	–	–	﹤0.01%	933
2022 Q1	$7K	Hold	35	–	–	﹤0.01%	922
2021 Q4	$9K	Hold	35	–	–	﹤0.01%	880
2021 Q3	$10K	Hold	35	–	–	﹤0.01%	848
2021 Q2	$7K	Hold	35	–	–	﹤0.01%	920
2021 Q1	$7K	Hold	35	–	–	﹤0.01%	944
2020 Q4	$7K	Hold	35	–	–	﹤0.01%	909
2020 Q3	$5K	Buy	+35	New	+$5K	﹤0.01%	937

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Smithfield Trust's RGEN Position: Q1 2026 in Review

Smithfield Trust held its Repligen (RGEN) position steady in Q1 2026 at 35 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Smithfield Trust first reported a position in RGEN in Q3 2020 and has held it in 23 quarters since. The position peaked at $10K in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

Smithfield Trust held 35 shares of Repligen worth $4K as of Q1 2026.
Smithfield Trust left its Repligen share count unchanged in Q1 2026.
Repligen made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #1010 holding.
Smithfield Trust first reported a position in Repligen in Q3 2020 and has held it in 23 quarters since.
Smithfield Trust's Repligen position peaked at $10K in Q3 2021.
441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.